We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
NITROPRUSSIDE RMB, NITROPRUSSIDE SXP, NITROPRUSSIDE TLB (Southern XP IP Pty Ltd)
Product name
NITROPRUSSIDE RMB, NITROPRUSSIDE SXP, NITROPRUSSIDE TLB
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
131 (255 working days)
Active ingredients
Sodium nitroprusside
Registration type
New generic medicine
Indication
NITROPRUSSIDE RMB, NITROPRUSSIDE SXP, NITROPRUSSIDE TLB concentrated injection is indicated for:
- 1. Immediate reduction of blood pressure in patients with hypertensive crises. Concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.
- 2. Producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.
- 3. Short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. Patients should be commenced on oral therapy as soon as possible.